Advertisement

Journal of General Internal Medicine

, Volume 23, Issue 3, pp 275–282 | Cite as

The Relationship Between Alcohol Consumption and Glycemic Control Among Patients with Diabetes: The Kaiser Permanente Northern California Diabetes Registry

  • Ameena T. AhmedEmail author
  • Andrew J. Karter
  • E. Margaret Warton
  • Jennifer U. Doan
  • Constance M. Weisner
Original Article

Abstract

BACKGROUND

Alcohol consumption is a common behavior. Little is known about the relationship between alcohol consumption and glycemic control among people with diabetes.

OBJECTIVE

To evaluate the association between alcohol consumption and glycemic control.

DESIGN

Survey follow-up study, 1994–1997, among Kaiser Permanente Northern California members.

PATIENTS

38,564 adult diabetes patients.

MEASUREMENTS

Self-reported alcohol consumption, and hemoglobin A1C (A1C), assessed within 1 year of survey date. Linear regression of A1C by alcohol consumption was performed, adjusted for sociodemographic variables, clinical variables, and diabetes disease severity. Least squares means estimates were derived.

RESULTS

In multivariate-adjusted models, A1C values were 8.88 (lifetime abstainers), 8.79 (former drinkers), 8.90 (<0.1 drink/day), 8.71 (0.1–0.9 drink/day), 8.51 (1–1.9 drinks/day), 8.39 (2–2.9 drinks/day), and 8.47 (≥3 drinks/day). Alcohol consumption was linearly (p < 0.001) and inversely (p = 0.001) associated with A1C among diabetes patients.

CONCLUSIONS

Alcohol consumption is inversely associated with glycemic control among diabetes patients. This supports current clinical guidelines for moderate levels of alcohol consumption among diabetes patients. As glycemic control affects incidence of complications of diabetes, the lower A1C levels associated with moderate alcohol consumption may translate into lower risk for complications.

Key words

diabetes alcohol consumption hemoglobin A1C 

Notes

Acknowledgments

The authors thank Drs. Joe Selby and Robert Lipton for their helpful suggestions. This study was funded by NIAAA (R21 AA015721-01A1) and by the Kaiser Community Benefits Fund. Preliminary study findings were presented in abstract form at the Addictions Health Services Research Conference, October 23–25, 2006, Little Rock, AK.

Conflict of Interest

None disclosed.

References

  1. 1.
    Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. The impact of gender on amputation. J Foot Ankle Surg. 1997;36:66–9.PubMedGoogle Scholar
  3. 3.
    Morris AD, McAlpine R, Steinke D et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care. 1998;21:738–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care. 1983;6:87–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care. 1993;16:16–20.PubMedCrossRefGoogle Scholar
  6. 6.
    Trautner C, Haastert B, Giani G, Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19:1006–9.PubMedCrossRefGoogle Scholar
  7. 7.
    USRDS. USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2001. Bethesda, MD. Tertiary USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.Google Scholar
  8. 8.
    van Houtum WH, Lavery LA, Harkless LB. The impact of diabetes-related lower-extremity amputations in The Netherlands. J Diabetes Complications. 1996;10:325–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Standards of medical care in diabetes—2006. Diabetes Care. 2006;29 Suppl 1:S4–42.Google Scholar
  11. 11.
    Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National Survey on Drug Use and Health. 2004. Rockville, MD. Tertiary Overview of Findings from the 2003 National Survey on Drug Use and Health.Google Scholar
  13. 13.
    Carlsson S, Hammar N, Grill V, Kaprio J. Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study. Diabetes Care. 2003;26:2785–90.PubMedCrossRefGoogle Scholar
  14. 14.
    Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140:211–9.PubMedGoogle Scholar
  15. 15.
    Lu W, Jablonski KA, Resnick HE et al. Alcohol intake and glycemia in American Indians: the strong heart study. Metabolism. 2003;52:129–35.PubMedCrossRefGoogle Scholar
  16. 16.
    Nakanishi N, Suzuki K, Tatara K. Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2003;26:48–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Wannamethee SG, Camargo CA, Jr., Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003;163:1329–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Watanabe M, Barzi F, Neal B et al. Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese. Diabetes Res Clin Pract. 2002;57:191–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Franz MJ, Bantle JP, Beebe CA et al. Nutrition principles and recommendations in diabetes. Diabetes Care. 2004;27(Suppl 1):S36–46.PubMedGoogle Scholar
  20. 20.
    Gordon NP, Kaplan GA. Some evidence refuting the HMO “favorable selection” hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39.PubMedGoogle Scholar
  21. 21.
    Hiatt RA, Friedman GD. Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health. 1982;72:829–33.PubMedCrossRefGoogle Scholar
  22. 22.
    Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 2001;24:1144–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Iribarren C, Karter AJ, Go AS et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001;103:2668–73.PubMedGoogle Scholar
  25. 25.
    Karter AJ, Rowell SE, Ackerson LM et al. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 1999;22:938–43.PubMedCrossRefGoogle Scholar
  26. 26.
    Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23:477–83.PubMedCrossRefGoogle Scholar
  27. 27.
    Karter AJ, Ackerson LM, Darbinian JA et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519–27.PubMedCrossRefGoogle Scholar
  29. 29.
    Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396–402.PubMedCrossRefGoogle Scholar
  30. 30.
    Selby JV, Ettinger B, Swain BE, Brown JB. First 20 months’ experience with use of metformin for type 2 diabetes in a large health maintenance organization. Diabetes Care. 1999;22:38–44.PubMedCrossRefGoogle Scholar
  31. 31.
    Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24:1547–55.PubMedCrossRefGoogle Scholar
  32. 32.
    Gual A, Segura L, Contel M, Heather N, Colom J. Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcohol. 2002;37:591–6.PubMedGoogle Scholar
  33. 33.
    Gronbaek M, Heitmann BL. Validity of self-reported intakes of wine, beer and spirits in population studies. Eur J Clin Nutr. 1996;50:487–90.PubMedGoogle Scholar
  34. 34.
    Friesema IH, Veenstra MY, Zwietering PJ, Knottnerus JA, Garretsen HF, Lemmens PH. Measurement of lifetime alcohol intake: utility of a self-administered questionnaire. Am J Epidemiol. 2004;159:809–17.PubMedCrossRefGoogle Scholar
  35. 35.
    Harris TR, Wilsnack RW, Klassen AD. Reliability of retrospective self-reports of alcohol consumption among women: data from a U.S. national sample. J Stud Alcohol. 1994;55:309–14.PubMedGoogle Scholar
  36. 36.
    Bongers IM, van Oers JA. Mode effects on self-reported alcohol use and problem drinking: mail questionnaires and personal interviewing compared. J Stud Alcohol. 1998;59:280–5.PubMedGoogle Scholar
  37. 37.
    Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26:814–23.PubMedCrossRefGoogle Scholar
  38. 38.
    Li CL, Tsai ST, Chou P. Persistent impaired glucose tolerance, insulin resistance, and beta-cell dysfunction were independent predictors of type 2 diabetes. J Clin Epidemiol. 2005;58:728–32.PubMedCrossRefGoogle Scholar
  39. 39.
    Caballero AE. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep. 2004;4:237–46.PubMedCrossRefGoogle Scholar
  40. 40.
    Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med. 2005;22:1476–81.PubMedCrossRefGoogle Scholar
  41. 41.
    Mackenzie T, Brooks B, O’Connor G. Beverage intake, diabetes, and glucose control of adults in America. Ann Epidemiol. 2006;16:688–91.PubMedCrossRefGoogle Scholar
  42. 42.
    Shai I, Wainstein J, Harman-Boehm I et al. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: A Multi-center, randomized clinical intervention trial. Diabetes Care. 2007.Google Scholar
  43. 43.
    Avogaro A, Watanabe RM, Gottardo L, de Kreutzenberg S, Tiengo A, Pacini G. Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics. J Clin Endocrinol Metab. 2002;87:1233–38.PubMedCrossRefGoogle Scholar
  44. 44.
    Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care. 1994;17:115–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Hodge AM, Dowse GK, Collins VR, Zimmet PZ. Abnormal glucose tolerance and alcohol consumption in three populations at high risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1993;137:178–89.PubMedGoogle Scholar
  46. 46.
    Kiechl S, Willeit J, Poewe W et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Bmj. 1996;313:1040–44.PubMedGoogle Scholar
  47. 47.
    Mayer EJ, Newman B, Quesenberry CP, Jr., Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation. 1993;88:2190–7.PubMedGoogle Scholar
  48. 48.
    Razay G, Heaton KW, Bolton CH, Hughes AO. Alcohol consumption and its relation to cardiovascular risk factors in British women. Bmj. 1992;304:80–3.PubMedCrossRefGoogle Scholar
  49. 49.
    Zilkens RR, Puddey IB. Alcohol and cardiovascular disease—more than one paradox to consider. Alcohol and type 2 diabetes—another paradox? J Cardiovasc Risk. 2003;10:25–30.PubMedCrossRefGoogle Scholar
  50. 50.
    Meyer KA, Conigrave KM, Chu NF et al. Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. J Am Coll Nutr. 2003;22:185–94.PubMedGoogle Scholar
  51. 51.
    Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Jr., Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care. 2000;23:1630–36.PubMedCrossRefGoogle Scholar
  52. 52.
    Harding AH, Sargeant LA, Khaw KT et al. Cross-sectional association between total level and type of alcohol consumption and glycosylated haemoglobin level: the EPIC-Norfolk Study. Eur J Clin Nutr. 2002;56:882–90.PubMedCrossRefGoogle Scholar
  53. 53.
    Kroenke CH, Chu NF, Rifai N et al. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care. 2003;26:1971–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Gulliford MC, Ukoumunne OC. Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. Eur J Clin Nutr. 2001;55:615–23.PubMedCrossRefGoogle Scholar
  55. 55.
    Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.PubMedCrossRefGoogle Scholar
  56. 56.
    Sierksma A, Patel H, Ouchi N et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004;27:184–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Reijneveld SA, Stronks K. The impact of response bias on estimates of health care utilization in a metropolitan area: the use of administrative data. Int J Epidemiol. 1999;28:1134–40.PubMedCrossRefGoogle Scholar
  58. 58.
    Benfante R, Reed D, MacLean C, Kagan A. Response bias in the Honolulu Heart Program. Am J Epidemiol. 1989;130:1088–100.PubMedGoogle Scholar
  59. 59.
    Harald K, Salomaa V, Jousilahti P, Koskinen S, Vartiainen E. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92. J Epidemiol Community Health. 2007;61:449–54.PubMedCrossRefGoogle Scholar
  60. 60.
    Van Loon AJ, Tijhuis M, Picavet HS, Surtees PG, Ormel J. Survey non-response in the Netherlands: effects on prevalence estimates and associations. Ann Epidemiol. 2003;13:105–10.PubMedCrossRefGoogle Scholar
  61. 61.
    Gordon NP, Kaplan GA. Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente. Adv Health Econ Health Serv Res. 1991;12:19–39.PubMedGoogle Scholar
  62. 62.
    Ahmed AT, Karter AJ, Liu JY. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviors. Diabet Med. 2006;23:795–802.PubMedCrossRefGoogle Scholar
  63. 63.
    Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–65.Google Scholar
  64. 64.
    Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2007

Authors and Affiliations

  • Ameena T. Ahmed
    • 1
    Email author
  • Andrew J. Karter
    • 1
  • E. Margaret Warton
    • 1
  • Jennifer U. Doan
    • 2
  • Constance M. Weisner
    • 1
  1. 1.Kaiser Permanente Division of ResearchOaklandUSA
  2. 2.Permanente Medical GroupMilpitasUSA

Personalised recommendations